Uncategorized
What Analysts Are Saying About Neurocrine Biosciences Stock
Latest Ratings for NBIX Date Firm Action From To Mar 2022 Piper Sandler Downgrades Overweight Neutral Feb 2022 Goldman Sachs Upgrades Neutral Buy Feb 2022 Morgan Stanley Maintains Equal-Weight View More Analyst Ratings for NBIX View the Latest Analyst Ratings read more
Beyond The Numbers: 4 Analysts Discuss PJT Partners Stock
Latest Ratings for PJT Date Firm Action From To Mar 2022 Piper Sandler Maintains Overweight Feb 2022 Goldman Sachs Maintains Buy Nov 2021 Keefe, Bruyette & Woods Downgrades Outperform Market Perform View More Analyst Ratings for PJT View the Latest Analyst Ratings read more
Dogecoin, Shiba Inu Absent From 2024’s Top-Performing Meme Coins: Here’s Who Made The Cut
Bloomberg Senior ETF analyst Eric Balchunas showcased a PR pitch he received on mail, revealing the 20 best-performing meme coins of 2024. What Happened: Balchunas highlighted a list of the top-performing meme coins of 2024, compiled by Kryptocasinos. read more
Retail Investors Drive Demand For Personalized Tools And 24/7 Access
Retail investors are changing brokerages by demanding real-time tools and market access. Experts say education and personalization are key to success. read more
What’s Going On With Archer Aviation (ACHR) Stock?
Archer Aviation shares are trading higher by 10.7% during Friday’s session. The company recently partnered with Anduril for defense VTOLs, raised $430 million and expanded eVTOL efforts. read more
‘Sticky Inflation’ Appears ‘Less Stuck’ After November Consumer Price Data, Expert Says
Economists are weighing in on November’s cool PCE data and what it could mean for the Federal Reserve and markets heading into 2025. read more
